Mumbai: There is no restriction on Patanjali Ayurved’s Swasari Coronil kit for “COVID management” claims Yog guru Ramdev and he also said that it will be available across the country.
“The Ministry of AYUSH stated that Patanjali has done appropriate work for COVID management. It said that Patanjali has started working in the right direction. We have obtained a license for these medicines from the State Department which is linked to the Ministry of AYUSH … The AYUSH Ministry said that Patanjali worked for COVID management. The treatment word is not used. These medicines have no metallic items,” Ramdev said in a press conference.
“We have no disagreement with the Ministry of AYUSH. Now, there is no restriction on Coronil, Swasari, Giloy, Tulsi, Ashwagandha. Starting today, these medicines (Swasari Coronil Kit will be available in the country without any legal restrictions. There is no restriction on it. I thank the AYUSH Ministry and the Narendra Modi government,” he said.
Ramdev said that Patanjali has conducted randomized, double-blind, and placebo-controlled clinical trials. “In 3 days, 69 percent, 100 percent of the patients tested negative in 7 days. We submitted the data to the Ministry of AYUSH. We have submitted our clinical trial research to the Ministry of AYUSH. Our research is in line with all protocols.”
He informed that Patanjali has completed three-tier research of more than 10 diseases.
“We have done clinical trials on coronaviruses. We have completed three-tier research of more than 10 diseases including hypertension, heart disease, asthma, arthritis, dengue, chikungunya, swine flu. We are not doing research on virology for the first time,” he said.
Last week, Patanjali Ayurved launched ‘Coronil and Swasari’, claiming to be the Ayurvedic cure for the treatment of COVID-19 and said that clinical trials have shown favorable results.
Later, the Ministry of AYUSH said that it has taken cognizance of the media reports about the Ayurvedic medicines developed by Patanjali Ayurved Ltd, Haridwar for the treatment of COVID-19, and said that the company has been told to “stop advertising” Do “or making such claims public. The issue has been duly investigated ”.